心脏手术中冷藏与室温血小板对比:CHIPS随机临床试验
CHIPS试验在27个中心纳入989例心脏手术体外循环患者,按2:1随机接受最长21天冷藏血小板或最长7天室温血小板。冷藏血小板在止血疗效上不劣于室温血小板,且24小时胸管引流量无统计学差异;冷藏组再次探查率升高,但血栓事件等安全性指标无差异。
要点
- 冷藏血小板(最长21天)止血疗效不劣于室温血小板(最长7天)。
- 24小时胸管引流量两组无统计学差异。
- 冷藏组再次探查率升高,但血栓事件等安全性指标无差异。
核心结论
- 对于心脏手术患者,冷藏最长21天的血小板在控制活动性手术出血方面不劣于室温血小板。
研究设计与样本
- 3期、多中心、随机、部分盲法、适应性、非劣效、储存时间范围试验,在美国和澳大利亚27个中心开展。
- 共1000例接受血小板输注,989例纳入主要分析(冷藏组650例,室温组339例)。
- 按2:1随机接受最长21天冷藏血小板或最长7天室温血小板。
主要发现
- 主要终点止血疗效评分(1-5分,分值越高出血越重)显示冷藏血小板在所有储存时间点非劣效概率均大于99.9%。
- 汇总各储存时间,冷藏组与室温组平均差异为0.09(95%可信区间 -0.06 至 0.23)。
- 24小时胸管引流量中位数(IQR):冷藏组8.9 mL/kg(5.2-15.4),室温组8.4 mL/kg(5.5-15.9),中位数差异0.4(95% CI -1.0 至 1.5),无统计学差异。
- 事后分析将冷藏组作为单组,止血疗效评分均值(SD)冷藏组3.08(1.15) vs 室温组2.99(1.10)。
- 静脉或动脉血栓事件、输血相关不良事件、急性呼吸窘迫综合征、肾衰竭、感染性休克和死亡率两组无差异,但冷藏组再次探查率升高。
关键数值与推荐
- 非劣效界值为1分。
- 成功标准:至少一个≥7天的冷藏储存时间点非劣效后验概率≥97.5%。
- 主要终点止血疗效评分范围1-5分,分值越高出血越重。
临床怎么用
- 心脏手术活动性出血患者可考虑使用冷藏最长21天的血小板,以降低浪费和短缺、提高血小板可及性。
- 冷藏血小板或可纳入因室温血小板5-7天保质期而无法维持血小板的库存地点。
- 需关注冷藏组再次探查率升高,临床决策时综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients undergoing cardiac surgery with cardiopulmonary bypass often require platelet transfusions for bleeding. Platelets are routinely stored at room temperature (20-24 °C) for up to 5 to 7 days; however, cold storage (1-6 °C) may allow for increased storage duration without loss of hemostatic function. OBJECTIVE: To determine the maximum cold-storage duration, up to 21 days, for which cold-stored platelets (CSPs) are noninferior or superior in hemostatic efficacy to room-temperature platelets (RTPs) when transfused in actively bleeding patients undergoing cardiac surgery with cardiopulmonary bypass. DESIGN, SETTING, AND PARTICIPANTS: A phase 3, multicenter, randomized, partially blinded, adaptive, noninferiority, storage duration-ranging trial conducted in pediatric and adult patients undergoing cardiac surgery with planned cardiopulmonary bypass at 27 sites in the US and Australia from December 2021 to March 2025. Statistical analysis was conducted from September 9 to October 3, 2025. INTERVENTION: Patients were randomized 2:1 to receive CSPs with a maximum of 21 days of storage vs RTPs with a maximum of 7 days of storage. MAIN OUTCOMES AND MEASURES: The primary outcome was a hemostatic efficacy score with values ranging from 1 to 5 and higher values indicating greater bleeding. The noninferiority margin was 1 point. The success criterion was met if at least 1 cold-storage duration of 7 days or more had a posterior probability of noninferiority of at least 97.5%. The secondary outcome was 24-hour chest tube output. RESULTS: Of the 1000 patients who underwent platelet transfusion, 989 were included in the primary analysis (650 CSPs and 339 RTPs). The cohort had a mean (SD) age of 42.1 (30.1) years and 67.8% were male. CSPs were noninferior to RTPs for the primary outcome, with a probability of greater than 99.9% for all cold-storage durations. Pooled across storage durations, CSPs had a mean difference from RTPs of 0.09 (95% credible interval, -0.06 to 0.23). Median (IQR) chest tube output at 24 hours (8.9 mL/kg [5.2-15.4] for CSPs vs 8.4 mL/kg [5.5-15.9] for RTPs; difference in medians, 0.4 [95% CI, -1.0 to 1.5]) was not statistically different between study groups. In a post hoc analysis, as all storage durations were noninferior, considering the CSPs as a single group, the hemostatic efficacy score was similar between both groups: mean (SD) of 3.08 (1.15) CSPs vs 2.99 (1.10) RTPs. There were no differences in venous or arterial thrombotic events, transfusion-associated adverse events, acute respiratory distress syndrome, kidney failure, septic shock, and mortality between the study groups, except for increased reexploration rates in the CSP group. CONCLUSIONS AND RELEVANCE: For patients undergoing cardiac surgery, CSPs stored up to 21 days are noninferior to RTPs for the control of active surgical bleeding. Use of CSPs may allow for increased availability of platelets by reducing wastage and shortages and may allow for incorporation of platelets into inventory at locations where platelets cannot be maintained due to the 5- to 7-day shelf life of RTPs. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04834414.
引用
- Spinella PC, Zantek ND, VanBuren JM, et al. Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial. JAMA. 2026. PMID: 42606886. doi:10.1001/jama.2026.13328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。